Alejandro Gonzalez Veliz: What If Inflammation Is the Hidden Driver of Cardiovascular Disease?
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“What if inflammation is the hidden driver of cardiovascular disease?
For decades, cholesterol has been the main focus of prevention. But growing evidence shows that chronic low-grade inflammation plays a central role in atherosclerosis, plaque rupture, myocardial infarction, and heart failure.
Inflammation promotes endothelial dysfunction, foam cell formation, and vulnerable plaques.
High-sensitivity C-reactive protein (hsCRP) helps identify residual inflammatory risk—even when LDL cholesterol is well controlled.
Clinical trials such as CANTOS, COLCOT, and LoDoCo2 demonstrated that targeting inflammation can reduce cardiovascular events.
The good news?
Lifestyle remains one of the most powerful anti-inflammatory therapies:
- Mediterranean diet
- Regular exercise
- Smoking cessation
- Healthy weight management
The future of cardiovascular prevention is no longer just about lowering cholesterol. It’s about extinguishing the silent fire within the arteries.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026